Introduction {#sec1-1}
============

Cerebral aspergillosis may occur due to hematogenous dissemination or by direct spread from paranasal sinuses.\[[@ref1]\] In immunocompetent hosts usually the disease is not suspected based on clinical or imaging features.\[[@ref2]\] We present a solid mass like presentation of cerebral aspergillosis in a 22-year-old-male where preoperatively a diagnosis of high grade glioma or lymphoma was suspected.

Case Report {#sec1-2}
===========

A 22-year-old-male presented with recurrent attacks of complex partial seizures with secondary generalization for 1 month, headache and blurring of vision with diplopia for 20 days. The headache was bifrontal in nature, moderate-to-severe associated with irritability. There was no cough, fever, ear discharge, nasal stuffiness, diarrhea, or high-risk behavior. On examination, the patient was conscious and disoriented. Bilateral pupils were reacting to light. Fundus examination revealed bilateral Grade 1 papilledema. Facial deviation was present toward the left side; however, there was no facial hypoesthesia. The power was 3/5 in left upper and lower limbs. Sensory examination was normal. The laboratory findings were as follows: hemoglobin (Hb), 14.2 g/dl; total leukocyte count, 15,500/mm^3^; differential leukocyte count, N70 E06 L20 M02; and serum creatinine, 1.1 mg/dl. HIV, viral markers, and diabetic workup were negative. Magnetic resonance imaging (MRI) brain was performed on a 3T scanner (Signa HDxT^®^, GE Healthcare, Milwaukee, Wisconsin). MRI showed a large T2 hypointense mass in the right temporal lobe with intense homogeneous postcontrast enhancement \[[Figure 1](#F1){ref-type="fig"}\]. The margins of mass were irregular with frond-like projections. There was extensive perilesional edema with midline shift and uncal herniation. Another small enhancing nodular lesion was also noted in the right frontal lobe.

![(a) T2-weighted image shows a hypointense mass (arrow) in temporal lobe with marked perilesional edema. (b) Diffusion-weighted image does not reveal diffusion restriction. (c) Lesion shows mild blooming (arrow) on susceptibility-weighted image. (d) Lesion is isointense to gray matter on noncontrast T1-weighted image. (e) Lesion shows homogeneous intense postcontrast enhancement. Margins of lesion are irregular with frond-like projections (arrow). (f) Another enhancing nodular lesion noted in the right frontal lobe (arrow). Inset show peak at 3.8 ppm on MRS from the temporal lobe lesion](IJABMR-8-269-g001){#F1}

Right frontotemporal craniotomy identified a mass at depth of 1 cm from the surface. It was gray-white, firm, poorly suckable, and mildly vascular with the well-defined plane of cleavage. Mass along with temporal lobe was excised. The histopathological examination was suggestive of central nervous system (CNS) aspergillosis \[[Figure 2](#F2){ref-type="fig"}\]. Microbiological examination also confirmed Aspergillus species. He was treated with Amphotericin B for 3 days, but due to drug reaction and hypokalemia, voriconazole was started. The patient was discharged in conscious and oriented state with persistent left hemiparesis and facial deviation.

![(a and b) Photomicrograph showing part of brain parenchyma replaced by granuloma comprising of multiple histiocytic giant cells (arrows) and lymphocytic infiltrates (H and E, ×100, H and E, ×200). (c) Multiple fungal hyphae (arrows) are seen (PAS, ×400). (d) Fungal hyphae are seen branching at acute angle (arrows) suggestive of *Aspergillus species* (CMS, ×400)](IJABMR-8-269-g002){#F2}

Discussion {#sec1-3}
==========

Cerebral aspergillosis occurs mostly in immunocompromised patients with high mortality.\[[@ref1][@ref2][@ref3]\] In immunocompromised patients, pathological examination usually reveals single or multiple abscesses with marked vascular invasion.\[[@ref2]\] Recently, there is a rise in fungal infections involving CNS in apparently immunocompetent patients.\[[@ref3]\] The immunocompetent hosts respond differently to the organism and generally present with granulomatous masses or meningitis. A rare mass like or tumoral form of cerebral aspergillosis has been described mostly in immunocompetent patients.\[[@ref4][@ref5][@ref6][@ref7]\]

In this case, due to the presence of solid mass-like enhancement diagnosis of a high grade glioma or lymphoma was suggested preoperatively. Retrospective analysis of MR images suggest some imaging features in favor of fungal infection like T2 hypointensity, irregular frond-like margins, and absence of choline peak. Hemorrhage is commonly seen in cerebral aspergillosis as low-signal intensity often at the periphery of the lesions on T2-weighted MR images.\[[@ref1]\] Another reason for low T2 signal intensity is elevated levels of iron, magnesium, zinc, calcium, chromium, and nickel in Aspergillus colonies.\[[@ref7]\] However, hypercellular neoplasms such as lymphoma may also be T2 hypointense. The fungal abscesses tend to have irregular walls with intracavitary projections; however, irregular frond-like outer margins has not been described.\[[@ref8]\] In this case, there was a single prominent peak at 3.8 ppm, with absence of choline peak. Peaks at 3.6 and 3.8 ppm have been described in wall of fungal abscesses attributed to trehalose.\[[@ref8]\] However, in this case, a single peak at 3.8 ppm could be due to mannitol, which was given to reduce brain edema. Mannitol has been described as a cause of potential pitfall for peak assignment on MR spectroscopy in a case of recurrent meningioma.\[[@ref9]\]

To summarize, cerebral aspergillosis can occur in immunocompetent individuals and may mimic a cerebral neoplasm. The presence of imaging findings such as T2 hypointensity, irregular frond-like margins, and absence of choline peak may be the clues toward a fungal etiology.
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